WhiteLab Genomics Raises €23.2M Series B to Advance AI-Powered Genomic Medicines
Paris-based biotech company WhiteLab Genomics has raised €23.2 million ($26 million) in a Series B funding round. The company uses AI to help design the building blocks used in genomic…